NFKB1 and neoplasm: Moreover, metadherin activates NF-κB directly by interacting with its p65 subunit or indirectly via degradation of NF-κB inhibitors, with subsequent upregulation of NF-κB-related gene expression that enhances cell survival, migration, and invasion, resulting in tumor progression and spread [42].